PharmaShots | Incisive News in 3 Shots

Subscribe Now

immunology and pain

Lilly Signs a License Agreement with Lycia to Develop Novel LYTAC Degraders

Lilly Signs a License Agreement with Lycia to Develop Novel LYTAC Degraders

August 26, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us